Statistics

	Views
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution	108

	Downloads
6807-30551.pdf	79

Select a period of time:

	Views
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution	30

	Downloads
6807-30551.pdf	8

	Downloads
United States	6
Brazil	1

	Downloads

RUNA digital repository